Literature DB >> 32968197

Monocyte-derived dendritic cells link localized secretory IgA deficiency to adaptive immune activation in COPD.

Timothy S Blackwell1,2, Vasiliy V Polosukhin3, Bradley W Richmond1,2, Samira Mansouri4, Ana Serezani2, Sergey Novitskiy2, Jessica B Blackburn2, Rui-Hong Du2, Hubaida Fuseini2, Sergey Gutor2, Wei Han2, Jacob Schaff2, Georgii Vasiukov2, Matthew K Xin2, Dawn C Newcomb2, Lei Jin4.   

Abstract

Although activation of adaptive immunity is a common pathological feature of chronic obstructive pulmonary disease (COPD), particularly during later stages of the disease, the underlying mechanisms are poorly understood. In small airways of COPD patients, we found that localized disruption of the secretory immunoglobulin A (SIgA)-containing mucosal immunobarrier correlated with lymphocyte accumulation in airway walls and development of tertiary lymphoid structures (TLS) around small airways. In SIgA-deficient mice, we observed bacterial invasion into the airway epithelial barrier with lymphocytic infiltration and TLS formation, which correlated with the progression of COPD-like pathology with advanced age. Depletion of either CD4+ or CD8+ T lymphocytes reduced the severity of emphysema in SIgA-deficient mice, indicating that adaptive immune activation contributes to progressive lung destruction. Further studies revealed that lymphocyte infiltration into the lungs of SIgA-deficient mice was dependent on monocyte-derived dendritic cells (moDCs), which were recruited through a CCR2-dependent mechanism in response to airway bacteria. Consistent with these results, we found that moDCs were increased in lungs of COPD patients, along with CD4+ and CD8+ effector memory T cells. Together, these data indicate that endogenous bacteria in SIgA-deficient airways orchestrate a persistent and pathologic T lymphocyte response through monocyte recruitment and moDC differentiation.

Entities:  

Year:  2020        PMID: 32968197      PMCID: PMC7946625          DOI: 10.1038/s41385-020-00344-9

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  62 in total

Review 1.  The innate immune response of the respiratory epithelium.

Authors:  G Diamond; D Legarda; L K Ryan
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

2.  Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease.

Authors:  Vasiliy V Polosukhin; Justin M Cates; William E Lawson; Rinat Zaynagetdinov; Aaron P Milstone; Pierre P Massion; Sebahat Ocak; Lorraine B Ware; Jae Woo Lee; Russell P Bowler; Alexey V Kononov; Scott H Randell; Timothy S Blackwell
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

Review 3.  The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces.

Authors:  Charlotte S Kaetzel
Journal:  Immunol Rev       Date:  2005-08       Impact factor: 12.988

Review 4.  Role of secretory IgA in infection and maintenance of homeostasis.

Authors:  Blaise Corthésy
Journal:  Autoimmun Rev       Date:  2012-11-29       Impact factor: 9.754

5.  Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease.

Authors:  C Pilette; V Godding; R Kiss; M Delos; E Verbeken; C Decaestecker; K De Paepe; J P Vaerman; M Decramer; Y Sibille
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

Review 6.  Transepithelial transport of immunoglobulins.

Authors:  K E Mostov
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

Authors:  Claus F Vogelmeier; Gerard J Criner; Fernando J Martinez; Antonio Anzueto; Peter J Barnes; Jean Bourbeau; Bartolome R Celli; Rongchang Chen; Marc Decramer; Leonardo M Fabbri; Peter Frith; David M G Halpin; M Victorina López Varela; Masaharu Nishimura; Nicolas Roche; Roberto Rodriguez-Roisin; Don D Sin; Dave Singh; Robert Stockley; Jørgen Vestbo; Jadwiga A Wedzicha; Alvar Agustí
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

Review 8.  Barrier function of airway tract epithelium.

Authors:  Shyamala Ganesan; Adam T Comstock; Uma S Sajjan
Journal:  Tissue Barriers       Date:  2013-05-30

9.  Secretory IgA: Designed for Anti-Microbial Defense.

Authors:  Per Brandtzaeg
Journal:  Front Immunol       Date:  2013-08-06       Impact factor: 7.561

10.  Multi-faceted functions of secretory IgA at mucosal surfaces.

Authors:  Blaise Corthésy
Journal:  Front Immunol       Date:  2013-07-12       Impact factor: 7.561

View more
  4 in total

1.  Secretory Cells Are the Primary Source of pIgR in Small Airways.

Authors:  Jessica B Blackburn; Jacob A Schaff; Sergey Gutor; Rui-Hong Du; David Nichols; Taylor Sherrill; Austin J Gutierrez; Matthew K Xin; Nancy Wickersham; Yong Zhang; Michael J Holtzman; Lorraine B Ware; Nicholas E Banovich; Jonathan A Kropski; Timothy S Blackwell; Bradley W Richmond
Journal:  Am J Respir Cell Mol Biol       Date:  2022-09       Impact factor: 7.748

2.  Monocyte-Derived Dendritic Cells (moDCs) Differentiate into Bcl6+ Mature moDCs to Promote Cyclic di-GMP Vaccine Adjuvant-Induced Memory TH Cells in the Lung.

Authors:  Samira Mansouri; Divya S Katikaneni; Himanshu Gogoi; Lei Jin
Journal:  J Immunol       Date:  2021-04-19       Impact factor: 5.422

Review 3.  Extracellular Vesicles as Central Mediators of COPD Pathophysiology.

Authors:  Derek W Russell; Kristopher R Genschmer; J Edwin Blalock
Journal:  Annu Rev Physiol       Date:  2021-11-01       Impact factor: 19.318

Review 4.  Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation.

Authors:  Charlotte Domblides; Juliette Rochefort; Clémence Riffard; Marylou Panouillot; Géraldine Lescaille; Jean-Luc Teillaud; Véronique Mateo; Marie-Caroline Dieu-Nosjean
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.